RDHL REDHILL BIOPHARMA LTD
FollowSPONSORED ADR (ADR), issuer CIK 1553846
17 managers (17 13F filers) reported a position in RDHL shares at 2025-12-31, 499,476 shares in all. 3 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 17
- 13F filers
- 17
- New
- 3
- Added
- 3
- Reduced
- 3
- Sold out
- 1
- Shares held by filers
- 499,476
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Raday Gileadofficer (Chief Operating Officer) | 2026-10-01 | -14,310,000 S | $0.0001 | Form 4 |
13F holders, Q4 2025
Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Raday Gilead sold 14,310,000 RDHL shares on 2026-10-01, Form 4 filed 2026-10-06. 0001178913-26-004715
Accepted , ingested